NEVVI Medicare utilization intelligence
or

← back

Provider profile

ROTTMANN, EVA DO

Rheumatology · NPI 1487049532 · SILVER SPRING, MD

1
Groups
52
Codes · 2024
43,181
Disclosed services

ROTTMANN, EVA is a Rheumatology in SILVER SPRING, MD, a member of 1 medical group, who billed 52 distinct codes to Medicare Part B in 2024.

Groups: ARTHRITIS AND RHEUMATISM ASSOCIATES PC (ROCKVILLE, MD)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒

Provider overview · all codes · CY2024

43,181
disclosed services
52
codes billed to Medicare Part B
Prior year · CY2023 27,059 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J3111 Injection, romosozumab-aqqg, 1 mg
J0897 Injection, denosumab, 1 mg
J3262 Injection, tocilizumab, 1 mg
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1745 Injection, infliximab, excludes biosimilar, 10 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
36415 Insertion of needle into vein for collection of blood sample
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
86140 Measurement c-reactive protein for detection of infection or inflammation
80053 Blood test, comprehensive group of blood chemicals
85652 Red blood cell sedimentation rate, to detect inflammation, automated
86235 Measurement of antibody for assessment of autoimmune disorder, any method
96372 Injection of drug or substance under skin or into muscle
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
96413 Administration of chemotherapy into vein, 1 hour or less
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J3489 Injection, zoledronic acid, 1 mg
86160 Measurement of complement (immune system proteins), antigen,
77080 Dxa bone density measurement of hip, pelvis, spine
82306 Vitamin d-3 level
76881 Complete ultrasound scan of joint
20611 Aspiration and/or injection of fluid large joint using ultrasound guidance
73130 X-ray of hand, minimum of 3 views
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
73110 X-ray of wrist, minimum of 3 views
84550 Uric acid level, blood
86200 Measurement of antibody for rheumatoid arthritis assessment
86255 Screening test for antibody to noninfectious agent
86431 Rheumatoid factor level
96415 Administration of chemotherapy into vein, each additional hour
86147 Cardiolipin antibody (tissue antibody) measurement
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
84165 Protein measurement, serum
86038 Screening test for autoimmune disorder
73562 X-ray of knee, 3 views
96375 Injection of additional new drug or substance into vein
76882 Limited ultrasound scan of joint or other extremity structure except blood vessels
84155 Total protein level, blood
76942 Ultrasonic guidance for needle placement
72100 X-ray of lower and sacral spine, 2-3 views
76536 Ultrasound scan of head and neck soft tissue
82310 Calcium level, total
87081 Screening test for pathogenic organisms
89051 Body fluid cell count with cell identification
89060 Crystal identification from tissue or body fluid
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
20551 Injection into tendon at attachment to bone or muscle
86376 Microsomal antibodies (autoantibody) measurement
86800 Thyroglobulin (thyroid protein) antibody measurement

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.